First Quadrant’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-130,100
Closed -$1.1M 434
2021
Q4
$1.1M Hold
130,100
0.12% 154
2021
Q3
$1.17M Hold
130,100
0.14% 144
2021
Q2
$1.29M Hold
130,100
0.15% 138
2021
Q1
$928K Hold
130,100
0.1% 173
2020
Q4
$684K Hold
130,100
0.07% 204
2020
Q3
$371K Sell
130,100
-55,385
-30% -$204K 0.05% 260
2020
Q2
$644K Buy
+185,485
New +$639K 0.09% 217
2017
Q1
Sell
-227
Closed -$6K 834
2016
Q4
$6K Buy
+227
New +$5.61K ﹤0.01% 815
2014
Q2
Sell
-103,900
Closed -$3.29M 824
2014
Q1
$3.29M Hold
103,900
0.07% 249
2013
Q4
$2.63M Buy
+103,900
New +$2.49M 0.06% 275
2013
Q3
Sell
-109
Closed -$2K 812
2013
Q2
$2K Buy
+109
New +$2.38K ﹤0.01% 792

Other funds holding PTEN

First Quadrant's PTEN Position: Q1 2022 in Review

First Quadrant sold out of Patterson-UTI (PTEN) in Q1 2022, closing a stake of 130,100 shares — an estimated $1.1M sold.

First Quadrant first reported a position in PTEN in Q2 2013 and held it in 11 quarters. The position peaked at $3.29M in Q1 2014. 271 funds tracked by Wall St. Rank hold PTEN as of Q1 2022.

  • First Quadrant reported no remaining Patterson-UTI position as of Q1 2022 after selling out during the quarter.
  • First Quadrant sold 130,100 Patterson-UTI shares in Q1 2022, an estimated $1.1M.
  • First Quadrant first reported a position in Patterson-UTI in Q2 2013 and held it in 11 quarters.
  • First Quadrant's Patterson-UTI position peaked at $3.29M in Q1 2014.
  • 271 funds tracked by Wall St. Rank held Patterson-UTI as of Q1 2022.

Based on First Quadrant's 13F filing for Q1 2022, filed 21 Apr 2022.